SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T20:19:21Z

Recent reported activity

0purchase rows on this page

0sale rows on this page

115matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-17Filed 2026-08-19	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 100% vested. F2 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F3 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F4 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 2,623 restricted stock units vest on 8/15/2027. F9 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. F10 4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029. F11 23,985 restricted stock units vest on 8/17/2029. References: F5, F11	A Award / grantRestricted Stock Units · Derivative	23,985A	0	Direct	Form 4 ↗0000914190-26-000130
2026-08-17Filed 2026-08-19	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 100% vested. F2 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F3 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F4 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 2,623 restricted stock units vest on 8/15/2027. F9 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. F10 4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029. F11 23,985 restricted stock units vest on 8/17/2029. References: F5, F10	A Award / grantRestricted Stock Units · Derivative	14,762A	0	Direct	Form 4 ↗0000914190-26-000130
2026-08-17Filed 2026-08-19	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 100% vested. F2 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F3 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F4 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F5 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F6 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F7 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. F8 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 794 restricted stock units vest on 5/1/2027. F11 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F12 1,869 restricted stock units vest on 8/15/2027. F13 2,177 restricted stock units vest on 8/15/2027, and 2,176 restricted stock units vest on 8/15/2028. F14 245 restricted stock units vest on each of 3/2/2027, 3/2/2028 and 3/2/2029. F15 2,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029. F16 14,140 restricted stock units vest on 8/17/2029. References: F8, F16	A Award / grantRestricted Stock Units · Derivative	14,140A	0	Direct	Form 4 ↗0000914190-26-000129
2026-08-17Filed 2026-08-19	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 100% vested. F2 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F3 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F4 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F5 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F6 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F7 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. F8 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 794 restricted stock units vest on 5/1/2027. F11 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F12 1,869 restricted stock units vest on 8/15/2027. F13 2,177 restricted stock units vest on 8/15/2027, and 2,176 restricted stock units vest on 8/15/2028. F14 245 restricted stock units vest on each of 3/2/2027, 3/2/2028 and 3/2/2029. F15 2,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029. F16 14,140 restricted stock units vest on 8/17/2029. References: F8, F15	A Award / grantRestricted Stock Units · Derivative	8,702A	0	Direct	Form 4 ↗0000914190-26-000129
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F6	M Exercise / conversionRestricted Stock Units · Derivative	2,332D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	1,669D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	49D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	4,432D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	370D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F1	D Other reported codePerformance Stock Option (Right to Buy) · Derivative	11,929D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	1,366D	72.4	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	4,420A	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F7	M Exercise / conversionRestricted Stock Units · Derivative	11,785D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F6	M Exercise / conversionRestricted Stock Units · Derivative	8,543D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F5	D Other reported codePerformance Restricted Stock Units · Derivative	8,698D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F5	M Exercise / conversionPerformance Restricted Stock Units · Derivative	725D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F4	D Other reported codePerformance Restricted Stock Units · Derivative	8,190D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F4	M Exercise / conversionPerformance Restricted Stock Units · Derivative	683D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F2	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	23,949D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,044D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	10,955D	72.4	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	21,736A	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	3,226D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	2,623D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	8,376D	0	Direct	Form 4/A ↗0000914190-26-000170

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.